Cytoskeleton and Molecular Motors in the Causation of Motor Neuron Diseases
- Fabio Andre Amaral Lopes Simoes(Author)
- Brighton and Sussex Medical School,
Student thesis:
Student thesis
Doctoral Thesis
About the thesis
Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy with lower<br/>extremity predominance (SMA-LED) are motor neuron diseases defined by the<br/>loss of motor neurons. RNA metabolism and molecular transport have both<br/>become increasingly implicated in the pathogenesis of motor neuron diseases. As<br/>such, this thesis explores the role of TAR-DNA binding protein 43 (TDP-43) in the<br/>regulation of peripherin expression in ALS, and the molecular consequences of<br/>mutations in DYNC1H1, a component of the cytoplasmic dynein motor complex, in<br/>SMA-LED.<br/>TDP-43 is a DNA/RNA binding protein implicated in ALS pathogenesis. Recent<br/>evidence suggests that TDP-43 regulates peripherin, an ALS associated<br/>intermediate filament protein. Here, analysis of peripherin in the lumbar spinal cord<br/>of TDP-43<sup>+/F210I</sup> mice revealed a significant increase in the levels of Per-45, a shift<br/>towards an increase in Per-58 in the Triton X-100 soluble fraction that did not<br/>reach statistical significance, and an increase in an isoform of 50 kDa in the<br/>insoluble fraction. These changes in the expression of peripherin in TDP-43<sup>+/F210I</sup><br/>mice may indicate a regulatory role for TDP-43 in peripherin expression, which<br/>could contribute to ALS pathology.<br/>Furthermore, there is evidence that defects in neurodevelopment are present in<br/>SMA-LED. Analysis of paxillin, a key focal adhesion protein in mouse embryonic<br/>fibroblasts from the Legs at odd angles (Loa) model of SMA-LED was performed,<br/>which indicated a reduction in its expression which may underpin the previously<br/>reported migration phenotypes in these cells. This data provides further evidence<br/>that SMA-LED may be a neurodevelopmental disorder. Furthermore, analysis<br/>revealed that the Golgi apparatus in DYNC1H1<sup>+/D338N</sup> patient fibroblasts was<br/>significantly condensed, while in BICD2<sup>+/I189F</sup> fibroblasts there was a decrease in<br/>localisation of dynein to the Golgi. The lack of dynein at the Golgi in BICD2<sup>+/I189F</sup><br/>fibroblasts indicates that BICD2 may be necessary for the recruitment of the<br/>molecular motor to the organelle. These Golgi phenotypes may also contribute to<br/>impaired migration in disease. Importantly, analysis of DYNC1H1<sup>+/D338N</sup> patient<br/>fibroblasts and mouse embryonic fibroblasts (MEFs) from the Loa mouse strain<br/>showed a significant decrease in α-tubulin acetylation, a phenotype previously<br/>seen in another DYNC1H1 substitution. In conclusion, these data support previous data which suggested that peripherin<br/>expression is altered in the context of TDP-43 mutations, potentially contributing to<br/>ALS pathology. Additionally, Golgi phenotypes were found in both<br/>DYNC1H1<sup>+/D338N</sup> and BICD2<sup>+/I189F</sup> fibroblasts with potential consequences for<br/>cellular migration. Finally, decreased microtubule acetylation may be a common<br/>factor in SMA-LED linked with DYNC1H1 mutations. The conserved nature of this<br/>phenotype could indicate a potential target for therapeutics.
Thesis information
Thesis Award Date
02/2018Qualification Level
Doctoral ThesisOriginal Language
EnglishThesis Managed By
Supervisors
P Nigel Leigh (Supervisor)
